Table 6.

Test accuracy for diagnostic strategy

Test resultNo. of results per 1000 patients tested (95% CI)No. of participants (studies)Certainty of the evidence (GRADE)
Prevalence 15%* in patients suspected of having LE DVTPrevalence 40%* in patients suspected of having LE DVT
True positives 146 (132-149) 388 (352-396) 105 (1) ⊕⊕◯◯Low 
False negatives 4 (1-18) 12 (4-48) 
True negatives 842 (731-850) 594 (516-600) 105 (1) ⊕⊕◯◯Low 
False positives 8 (1-119) 6 (1-84) 
Inconclusive test results 105 (1)  
Complications arising from the diagnostic test NA 
Test resultNo. of results per 1000 patients tested (95% CI)No. of participants (studies)Certainty of the evidence (GRADE)
Prevalence 15%* in patients suspected of having LE DVTPrevalence 40%* in patients suspected of having LE DVT
True positives 146 (132-149) 388 (352-396) 105 (1) ⊕⊕◯◯Low 
False negatives 4 (1-18) 12 (4-48) 
True negatives 842 (731-850) 594 (516-600) 105 (1) ⊕⊕◯◯Low 
False positives 8 (1-119) 6 (1-84) 
Inconclusive test results 105 (1)  
Complications arising from the diagnostic test NA 

D-dimer for “DVT unlikely” patients (if positive proximal compression US; if negative 3-month follow-up); proximal compression US for “DVT likely” patients (if positive repeat US at 1 week, if negative rule out). Patient or population: Patients with suspected recurrent lower extremity deep vein thrombosis. Setting: Inpatient and outpatient. Pooled sensitivity: 0.97 (95% CI, 0.88-0.99). Pooled specificity: 0.99 (95% CI, 0.86-1.00).

*

Prevalence of recurrent VTE was estimated to be 13% (1 year) to 30% (10 years) based on the review (20% used in the table).61

Clinical PTP and D-dimer used to evaluate patients with suspected recurrent DVT, prevalence 44.8% (40% used in table).56

Certainty of evidence was downgraded twice for serious imprecision given the small population size from the 2 recurrent lower extremity DVT studies identified for analysis.

or Create an Account

Close Modal
Close Modal